The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
• We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surger...
Ausführliche Beschreibung
Autor*in: |
Zhai, Lijie [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
---|
Umfang: |
5 |
---|
Übergeordnetes Werk: |
Enthalten in: New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR - Song, Chun-hui ELSEVIER, 2023, Burlington, Mass |
---|---|
Übergeordnetes Werk: |
volume:22 ; year:2015 ; number:12 ; pages:1964-1968 ; extent:5 |
Links: |
---|
DOI / URN: |
10.1016/j.jocn.2015.06.018 |
---|
Katalog-ID: |
ELV029119502 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV029119502 | ||
003 | DE-627 | ||
005 | 20230623195524.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jocn.2015.06.018 |2 doi | |
028 | 5 | 2 | |a GBVA2015016000009.pica |
035 | |a (DE-627)ELV029119502 | ||
035 | |a (ELSEVIER)S0967-5868(15)00358-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 540 |q VZ |
084 | |a 35.00 |2 bkl | ||
100 | 1 | |a Zhai, Lijie |e verfasserin |4 aut | |
245 | 1 | 4 | |a The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy |
264 | 1 | |c 2015 | |
300 | |a 5 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. | ||
650 | 7 | |a Brain tumor |2 Elsevier | |
650 | 7 | |a Immunosuppression |2 Elsevier | |
650 | 7 | |a Kynurenine |2 Elsevier | |
650 | 7 | |a Tryptophan |2 Elsevier | |
650 | 7 | |a Diagnostic |2 Elsevier | |
650 | 7 | |a Metabolism |2 Elsevier | |
650 | 7 | |a Glioblastoma multiforme |2 Elsevier | |
700 | 1 | |a Dey, Mahua |4 oth | |
700 | 1 | |a Lauing, Kristen L. |4 oth | |
700 | 1 | |a Gritsina, Galina |4 oth | |
700 | 1 | |a Kaur, Rajwant |4 oth | |
700 | 1 | |a Lukas, Rimas V. |4 oth | |
700 | 1 | |a Nicholas, M. Kelly |4 oth | |
700 | 1 | |a Rademaker, Alfred W. |4 oth | |
700 | 1 | |a Dostal, Carlos R. |4 oth | |
700 | 1 | |a McCusker, Robert H. |4 oth | |
700 | 1 | |a Raizer, Jeffrey J. |4 oth | |
700 | 1 | |a Parsa, Andrew T. |4 oth | |
700 | 1 | |a Bloch, Orin |4 oth | |
700 | 1 | |a Wainwright, Derek A. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Harcourt |a Song, Chun-hui ELSEVIER |t New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |d 2023 |g Burlington, Mass |w (DE-627)ELV009125612 |
773 | 1 | 8 | |g volume:22 |g year:2015 |g number:12 |g pages:1964-1968 |g extent:5 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.jocn.2015.06.018 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 35.00 |j Chemie: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 22 |j 2015 |e 12 |h 1964-1968 |g 5 | ||
953 | |2 045F |a 610 |
author_variant |
l z lz |
---|---|
matchkey_str |
zhailijiedeymahualauingkristenlgritsinag:2015----:hknrnnttytpartosponsitofrlolsoaain |
hierarchy_sort_str |
2015 |
bklnumber |
35.00 |
publishDate |
2015 |
allfields |
10.1016/j.jocn.2015.06.018 doi GBVA2015016000009.pica (DE-627)ELV029119502 (ELSEVIER)S0967-5868(15)00358-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Zhai, Lijie verfasserin aut The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme Elsevier Dey, Mahua oth Lauing, Kristen L. oth Gritsina, Galina oth Kaur, Rajwant oth Lukas, Rimas V. oth Nicholas, M. Kelly oth Rademaker, Alfred W. oth Dostal, Carlos R. oth McCusker, Robert H. oth Raizer, Jeffrey J. oth Parsa, Andrew T. oth Bloch, Orin oth Wainwright, Derek A. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:22 year:2015 number:12 pages:1964-1968 extent:5 https://doi.org/10.1016/j.jocn.2015.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 22 2015 12 1964-1968 5 045F 610 |
spelling |
10.1016/j.jocn.2015.06.018 doi GBVA2015016000009.pica (DE-627)ELV029119502 (ELSEVIER)S0967-5868(15)00358-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Zhai, Lijie verfasserin aut The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme Elsevier Dey, Mahua oth Lauing, Kristen L. oth Gritsina, Galina oth Kaur, Rajwant oth Lukas, Rimas V. oth Nicholas, M. Kelly oth Rademaker, Alfred W. oth Dostal, Carlos R. oth McCusker, Robert H. oth Raizer, Jeffrey J. oth Parsa, Andrew T. oth Bloch, Orin oth Wainwright, Derek A. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:22 year:2015 number:12 pages:1964-1968 extent:5 https://doi.org/10.1016/j.jocn.2015.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 22 2015 12 1964-1968 5 045F 610 |
allfields_unstemmed |
10.1016/j.jocn.2015.06.018 doi GBVA2015016000009.pica (DE-627)ELV029119502 (ELSEVIER)S0967-5868(15)00358-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Zhai, Lijie verfasserin aut The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme Elsevier Dey, Mahua oth Lauing, Kristen L. oth Gritsina, Galina oth Kaur, Rajwant oth Lukas, Rimas V. oth Nicholas, M. Kelly oth Rademaker, Alfred W. oth Dostal, Carlos R. oth McCusker, Robert H. oth Raizer, Jeffrey J. oth Parsa, Andrew T. oth Bloch, Orin oth Wainwright, Derek A. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:22 year:2015 number:12 pages:1964-1968 extent:5 https://doi.org/10.1016/j.jocn.2015.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 22 2015 12 1964-1968 5 045F 610 |
allfieldsGer |
10.1016/j.jocn.2015.06.018 doi GBVA2015016000009.pica (DE-627)ELV029119502 (ELSEVIER)S0967-5868(15)00358-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Zhai, Lijie verfasserin aut The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme Elsevier Dey, Mahua oth Lauing, Kristen L. oth Gritsina, Galina oth Kaur, Rajwant oth Lukas, Rimas V. oth Nicholas, M. Kelly oth Rademaker, Alfred W. oth Dostal, Carlos R. oth McCusker, Robert H. oth Raizer, Jeffrey J. oth Parsa, Andrew T. oth Bloch, Orin oth Wainwright, Derek A. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:22 year:2015 number:12 pages:1964-1968 extent:5 https://doi.org/10.1016/j.jocn.2015.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 22 2015 12 1964-1968 5 045F 610 |
allfieldsSound |
10.1016/j.jocn.2015.06.018 doi GBVA2015016000009.pica (DE-627)ELV029119502 (ELSEVIER)S0967-5868(15)00358-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Zhai, Lijie verfasserin aut The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme Elsevier Dey, Mahua oth Lauing, Kristen L. oth Gritsina, Galina oth Kaur, Rajwant oth Lukas, Rimas V. oth Nicholas, M. Kelly oth Rademaker, Alfred W. oth Dostal, Carlos R. oth McCusker, Robert H. oth Raizer, Jeffrey J. oth Parsa, Andrew T. oth Bloch, Orin oth Wainwright, Derek A. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:22 year:2015 number:12 pages:1964-1968 extent:5 https://doi.org/10.1016/j.jocn.2015.06.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 22 2015 12 1964-1968 5 045F 610 |
language |
English |
source |
Enthalten in New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR Burlington, Mass volume:22 year:2015 number:12 pages:1964-1968 extent:5 |
sourceStr |
Enthalten in New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR Burlington, Mass volume:22 year:2015 number:12 pages:1964-1968 extent:5 |
format_phy_str_mv |
Article |
bklname |
Chemie: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
Brain tumor Immunosuppression Kynurenine Tryptophan Diagnostic Metabolism Glioblastoma multiforme |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
authorswithroles_txt_mv |
Zhai, Lijie @@aut@@ Dey, Mahua @@oth@@ Lauing, Kristen L. @@oth@@ Gritsina, Galina @@oth@@ Kaur, Rajwant @@oth@@ Lukas, Rimas V. @@oth@@ Nicholas, M. Kelly @@oth@@ Rademaker, Alfred W. @@oth@@ Dostal, Carlos R. @@oth@@ McCusker, Robert H. @@oth@@ Raizer, Jeffrey J. @@oth@@ Parsa, Andrew T. @@oth@@ Bloch, Orin @@oth@@ Wainwright, Derek A. @@oth@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
ELV009125612 |
dewey-sort |
3610 |
id |
ELV029119502 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029119502</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623195524.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jocn.2015.06.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015016000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029119502</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0967-5868(15)00358-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhai, Lijie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Brain tumor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunosuppression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kynurenine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tryptophan</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnostic</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolism</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glioblastoma multiforme</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dey, Mahua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lauing, Kristen L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gritsina, Galina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaur, Rajwant</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lukas, Rimas V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nicholas, M. Kelly</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rademaker, Alfred W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dostal, Carlos R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McCusker, Robert H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raizer, Jeffrey J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parsa, Andrew T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bloch, Orin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wainwright, Derek A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Song, Chun-hui ELSEVIER</subfield><subfield code="t">New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR</subfield><subfield code="d">2023</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009125612</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1964-1968</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jocn.2015.06.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2015</subfield><subfield code="e">12</subfield><subfield code="h">1964-1968</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Zhai, Lijie |
spellingShingle |
Zhai, Lijie ddc 610 ddc 540 bkl 35.00 Elsevier Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy |
authorStr |
Zhai, Lijie |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009125612 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 540 VZ 35.00 bkl The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme Elsevier |
topic |
ddc 610 ddc 540 bkl 35.00 Elsevier Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme |
topic_unstemmed |
ddc 610 ddc 540 bkl 35.00 Elsevier Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme |
topic_browse |
ddc 610 ddc 540 bkl 35.00 Elsevier Brain tumor Elsevier Immunosuppression Elsevier Kynurenine Elsevier Tryptophan Elsevier Diagnostic Elsevier Metabolism Elsevier Glioblastoma multiforme |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
m d md k l l kl kll g g gg r k rk r v l rv rvl m k n mk mkn a w r aw awr c r d cr crd r h m rh rhm j j r jj jjr a t p at atp o b ob d a w da daw |
hierarchy_parent_title |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
hierarchy_parent_id |
ELV009125612 |
dewey-tens |
610 - Medicine & health 540 - Chemistry |
hierarchy_top_title |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV009125612 |
title |
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy |
ctrlnum |
(DE-627)ELV029119502 (ELSEVIER)S0967-5868(15)00358-6 |
title_full |
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy |
author_sort |
Zhai, Lijie |
journal |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
journalStr |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
1964 |
author_browse |
Zhai, Lijie |
container_volume |
22 |
physical |
5 |
class |
610 610 DE-600 540 VZ 35.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Zhai, Lijie |
doi_str_mv |
10.1016/j.jocn.2015.06.018 |
dewey-full |
610 540 |
title_sort |
kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy |
title_auth |
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy |
abstract |
• We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. |
abstractGer |
• We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. |
abstract_unstemmed |
• We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
container_issue |
12 |
title_short |
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy |
url |
https://doi.org/10.1016/j.jocn.2015.06.018 |
remote_bool |
true |
author2 |
Dey, Mahua Lauing, Kristen L. Gritsina, Galina Kaur, Rajwant Lukas, Rimas V. Nicholas, M. Kelly Rademaker, Alfred W. Dostal, Carlos R. McCusker, Robert H. Raizer, Jeffrey J. Parsa, Andrew T. Bloch, Orin Wainwright, Derek A. |
author2Str |
Dey, Mahua Lauing, Kristen L. Gritsina, Galina Kaur, Rajwant Lukas, Rimas V. Nicholas, M. Kelly Rademaker, Alfred W. Dostal, Carlos R. McCusker, Robert H. Raizer, Jeffrey J. Parsa, Andrew T. Bloch, Orin Wainwright, Derek A. |
ppnlink |
ELV009125612 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.jocn.2015.06.018 |
up_date |
2024-07-06T20:35:59.644Z |
_version_ |
1803863363046866944 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029119502</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623195524.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jocn.2015.06.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015016000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029119502</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0967-5868(15)00358-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhai, Lijie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We discuss the complex link between indoleamine 2,3 dioxygenase 1 (IDO1), tryptophan (Trp) and kynurenine (Kyn) in glioblastoma (GBM) patients. • We identify a potential new prognostic tool for GBM patient stratification. • We found that differences in the Kyn/Trp ratio appear ⩾10weeks post-surgery. • We introduce novel physiologically-relevant clinical data from GBM patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Brain tumor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunosuppression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kynurenine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tryptophan</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnostic</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolism</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glioblastoma multiforme</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dey, Mahua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lauing, Kristen L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gritsina, Galina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaur, Rajwant</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lukas, Rimas V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nicholas, M. Kelly</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rademaker, Alfred W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dostal, Carlos R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McCusker, Robert H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raizer, Jeffrey J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parsa, Andrew T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bloch, Orin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wainwright, Derek A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Song, Chun-hui ELSEVIER</subfield><subfield code="t">New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR</subfield><subfield code="d">2023</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009125612</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1964-1968</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jocn.2015.06.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2015</subfield><subfield code="e">12</subfield><subfield code="h">1964-1968</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.3996515 |